Back to Search
Start Over
Loss of IGF2 Imprinting: A Potential Marker of Colorectal Cancer Risk.
- Source :
-
Science . 3/14/2003, Vol. 299 Issue 5613, p1753-1755. 3p. 1 Chart. - Publication Year :
- 2003
-
Abstract
- Loss of imprinting (LOI), an epigenetic alteration affecting the insulin-like growth factor II gene (IGF2), is found in normal colonic mucosa of about 30% of colorectal cancer (CRC) patients, but it is found in only 10% of healthy individuals. In a pilot study to investigate the utility of LOI as a marker of CRC risk, we evaluated 172 patients at a colonoscopy clinic. The adjusted odds ratio for LOI in lymphocytes was 5.15 for patients with a positive family history [95% confidence interval (95% CI), 1.70 to 16.96; probability P = 0.002], 3.46 for patients with adenomas (95% CI, 1.14 to 11.37; P = 0.026), and 21.7 for patients with CRC (95% CI, 3.48 to 153.6; P = 0.0005). LOI can be assayed with a DNA-based blood test, and it may be a valuable predictive marker of an individual's risk for CRC. [ABSTRACT FROM AUTHOR]
- Subjects :
- *GENOMIC imprinting
*COLON cancer
Subjects
Details
- Language :
- English
- ISSN :
- 00368075
- Volume :
- 299
- Issue :
- 5613
- Database :
- Academic Search Index
- Journal :
- Science
- Publication Type :
- Academic Journal
- Accession number :
- 9389107
- Full Text :
- https://doi.org/10.1126/science.1080902